Unicycive Therapeutics (UNCY) Stock Highlights

0.97 | -6.73%

2024-04-26 03:49:20

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The companys lead drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycives other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury.

Statistics

Range Today

0.93 1.05

Volume Today 498.1K

Range 1 Year

0.47 1.82

Volume 1 Year 50.28M

Range 3 Year

0.4 8.73

Volume 3 Year 522.03M

Range 10 Year

0.4 8.73

Volume 10 Year 522.03M

Highlights

Market Capitalization 37.19M (micro)

Floating Shares 13.74M

Current Price 0.97

Price To Earnings -0.89

Price To Revenue 42.93

Earnings Per Share -1.28

Payout Ratio 0%

Performance

Latest -6.73%

1 Month -34.9%

3 Months -1.02%

6 Months +29.33%

1 Year -37.42%

3 Years -80.6%

5 Years -80.6%

10 Years -80.6%

Benchmarks

Market Capitalization

291 / 368

Gross Profits

0 / 278

Total Revenue

245 / 300

Total Rank

47 / 368

Free Cashflow

50 / 352

Performance 5 years

255 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.